tradingkey.logo

DRI Healthcare Q2 total income rises

ReutersAug 13, 2025 10:32 PM


Overview

  • DRI Healthcare Q2 total income at $44.1 mln, compared with 41.6 mln year ago

  • Co internalized investment management, aligning management with unitholders

  • Repurchased ~958K units for $9.1 mln under NCIB


Result Drivers

  • INTERNALIZATION - DRI Healthcare completed the internalization of its investment management function, aligning management with unitholders

  • EKTERLY INVESTMENT - Increased royalty entitlement on Ekterly by making a $22 mln optional payment, enhancing future cash flows

  • UNIT REPURCHASE - Repurchased ~958K units for $9.1 mln under NCIB, enhancing shareholder value


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Total Income

$44.13 mln

Q2 Adjusted Cash Earnings per Unit

$0.51

Q2 Net Earnings per Unit

$0.01

Q2 Net Income

$376,000

Q2 Adjusted EBITDA

$30.37 mln

Q2 Adjusted EBITDA Margin

76.0%


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the pharmaceuticals peer group is "buy"

  • Wall Street's median 12-month price target for Dri Healthcare Trust is C$19.25, about 22.3% above its August 13 closing price of C$14.95

Press Release: ID:nCNWMJ0F0a

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI